Product Information
SC-26196 is a potential new anti-cancer drug that inhibits the activation of fatty acid receptors. SC-26196 blocks receptor activity, which reduces the growth of cancer cells in cell culture. This drug also has inhibitory properties on tumor growth in xenograft mice, and may be useful for the treatment of cardiac dysfunction or other diseases related to fatty acid metabolism. SC-26196 is a complex molecule with high potential for drug interactions. It is a polyunsaturated molecule that can be activated by radiation and has been shown to have cardioprotective effects in rats with myocardial infarction.
Chemical properties
Technical inquiry about: 3D-TIA13659 SC-26196
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
